https://finance.yahoo.com/news/chroma-medicine-presents-preclinical-vivo-150000625.html
Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today presented new preclinical data...
Create an account or login to join the discussion